Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - CASH FROM OPERATIONS
Cash from Operations KALV - KalVista Pharmaceuticals, Inc.
-89.2 M
LAST VALUE
-6.87%
2 YEAR CAGR
-19.66%
5 YEAR CAGR
-33.78%
10 YEAR CAGR